New Location in Arlington Heights– Now Open

Learn More

Peer-review Journal Articles

  1. Epstein RJ, Hughes WF: “Lymphocyte-induced corneal neovascularization: A morphologic assessment”. Invest Ophthalmol Vis Sci 21 (1):87-94, 1981.
  2. Miller MT, Epstein RJ, Sugar J, et. al.: “Anterior segment anomalies associated with the fetal alcohol syndrome”. J Ped Ophthalmol and Strabismus 21:8, 1984.
  3. Epstein RJ, Wilson LA, Visvesvara GS, Plourde E: “Rapid diagnosis of Acanthamoeba keratitis from corneal scrapings using indirect fluorescent antibody staining”. Arch Ophthalmol 104:1318, 1986.
  4. Epstein RJ, Halkias A, Stulting RD, and Rodrigues MM: “Corneal opacities and anterior segment anomalies in DBA/2 mice: Models for corneal elastosis and the iridocorneal endothelial (ICE) syndrome”. Cornea 5:95, 1986.
  5. Epstein RJ, Fernandes A, Stulting RD, Tigges M, Wright JD, and Gammon JA: “The correction of aphakia in neonatal monkeys with extended-wear contact lenses: Corneal studies”. Ophthalmology 93: 1495, 1986.
  6. Epstein RJ, Stulting RD, and Kindle JC: “Blastogenesis induced by Herpes simplex virus in splenic mononuclear cells from inbred mice”. Curr. Eye Res. 6:145, 1987.
  7. Epstein RJ, and Stulting RD: “Corneal neovascularization induced by stimulated lymphocytes in inbred mice”. Invest Ophthalmol Vis Sci 28: 1505, 1987.
  8. Epstein RJ, Seedor JA, Dreizen NG et al.: “Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival”. Ophthalmology 94: 935, 1987.
  9. Epstein RJ, Stulting RD, Hendricks RL, Harris DM: “Corneal neovascularization: Pathogenesis and inhibition”. Cornea 6:250-257, 1987.
  10. Moore MB, McCulley JP, Newton C, Cobo LM, Foulks G, O’Day D, Johns K, Driebe WT, Wilson LA, Epstein RJ, Doughman DJ: “Acanthamoeba keratitis: A growing problem in soft and hard contact lens wearers”. Ophthalmol 94: 1654,1987.
  11. Epstein RJ, Fernandes A, Gammon JA: “The correction of aphakia in infants with hydrogel extended-wear contact lenses: Corneal studies.” Ophthalmol 95: 1102-1106, 1988.
  12. Visvesvara GS, Epstein RJ, et al: “Acanthamoeba keratitis associated with contact lenses-United States”. Morbidity and Mortality Weekly Report 35:405, 1988.
  13. Driebe WT Jr., Stern GA, Epstein RJ, Visvesvara GS, Adi M, Komadina T: “Acanthamoeba keratitis: Potential role for topical clotrimazole in combination chemotherapy”. Arch Ophthalmol 106:1196-1201, 1988.
  14. Epstein RJ, Vastine DW, Fried WI: “Removing the Stableflex intraocular lens during penetrating keratoplasty”. Ophthalmic Surg 20:171-172, 1989.
  15. Hendricks RL, Epstein RJ, Tumpey T: “The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis in mice”. Invest Ophthalmol Vis Sci. 30:105-115, 1989.
  16. Epstein RJ, Hendricks RL, Stulting RD: “Interleukin-2 induces corneal neovascularization in A/J mice”. Cornea 9:318-323, 1990.
  17. Hendricks RL, Barfknecht CF, Schoenwald RD, Epstein RJ, Sugar J: “The effect of flurbiprofen on herpes simplex virus type I stromal keratitis in mice”. Invest Ophthalmol Vis Sci 31:1503-1511, 1990.
  18. Hendricks RL, Epstein RJ, Viana MAG, Hoffman DA: “A reproducible method for injecting the mouse corneal stroma”. Invest Ophthalmol Vis Sci 32:366-370, 1991.
  19. Epstein RJ, Hendricks RL, Harris DM: “Photodynamic therapy for corneal neovascularization”. Cornea 10:424-432, 1991.
  20. Holland EJ, Alul IH, Meisler DM, Epstein RJ, et al.: “Subepithelial infiltrates in Acanthamoeba keratitis”. Am J Ophthalmol 112:414-418, 1991.
  21. Lipman RM, Epstein RJ, Hendricks RL: “Suppression of corneal neovascularization by cyclosporine”. Arch Ophthalmol 110:405-407, 1992.
  22. Nelson JD, Gordon JF, and the Chiron Keratoconjunctivitis Sicca Study Group: “Topical fibronectin in the treatment of keratoconjunctivitis sicca.” Am J Ophthalmol 114:441-447, 1992.
  23. Kay MD, Epstein RJ, Torczynski E: “Histopathology of acute intraoperative suprachoroidal hemorrhage associated with transscleral intraocular lens fixation”. J Cataract Refract Surg 19:83-87, 1993.
  24. Epstein RJ, Eiden SB: “Circumscribed posterior keratoconus”. J. Am. Optom Assn., 66:189-193, 1995.
  25. Baca LS, Epstein RJ: “Closed-chamber capsulorhexis for cataract extraction combined with penetrating keratoplasty”. J Cataract Refract Surg: 24: 581-584, 1998.
  26. Karp KO, Flood TP, Wilder AL, Epstein RJ: “Photic Maculopathy after Pterygium Excision”, AJO 128; 248-250, 1999.
  27. Konowal A, Morrison JC, Brown SVL, Cooke DL, Maguire LJ, Verdier DV, Fraunfelder FT, Dennis RF, Epstein RJ: “Irreversible corneal decompensation in patients treated with topical dorzolamide”, Am J Ophthalmol 127; 403-406, 1999
  28. Majmudar PA., Forstot SL, Dennis RF, Nirankari VS, Damiano RE, Brenart R, Epstein RJ: “Topical Mitomycin-C for subepithelial fibrosis after refractive corneal surgery”, Ophthalmol., 107:89-94, 2000.
  29. Karp KO, Hersh PS, Epstein RK: “Delayed keratitis after laser in-situ keratomileusis”, J Cataract Surg, 26: 925-928, 2000.
  30. Rao SN, Epstein RJ: Early onset ectasia following laser in-situ keratomileusis: Case report and literature review”. J. Refr. Surg 18: 177-184, 2002.
  31. Tang-Liu, DDS, Small D, Acheampong A, Reis B, Stern K, Stewart W, Berdy G, Epstein RJ, Forster R, Forstot L: “Blood concentrations of cyclosporin A during long-term treatment with cyclosporin A ophthalmic emulsions in patients with moderate to severe dry eye disease.” J Ocular Pharmacol and Therapeutics, 2002
  32. Rao S, Raviv T, Majmudar PA, Epstein RJ: “Role of ORBScan II in screening kerato-conus suspects before refractive corneal surgery”. Ophthalmol 109:1642-1646, 2002,
  33. Rao S, Konowal A, Murchison AE, Epstein RJ: “Enlargement of the temporal clear corneal incision to treat pre-existing astigmatism.” J Refract Surg 18:463-467. 2002.
  34. Muller LT, Candal EM, Epstein RJ, Dennis RF, Majmudar PA: “Transepithelial phototherapeutic keratectomy/photorefractive keratectomy (PTK/PRK) with adjunctive mitomycin-C for complicated LASIK flaps”. J Cat Refr Surg 31: 291-296, 2005
  35. Spanggord HM, Epstein RJ, Lane HA, Candal, EM, Klein, SR, Majmudar PA, Dennis RF: “Flap Suturing with Proparacaine For Recurrent Epithelial Ingrowth Following LASIK Surgery”. J Cat Refr Surg 31:916-921, 2005.
  36. Sheppard, JD, Epstein, RJ, Lattanzio FA, Marcantonio, D and Williams, PB: Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphrin ether. Am J Ophthalmol 141: 524-529, 2006.
  37. Klein, SR, Epstein RJ, Randleman JB, and Stulting RD: “Corneal ectasia after laser-in situ keratomileusis in patients without apparent preoperative risk factors. Cornea 25: 388-403, 2006.
  38. Majmudar, PA Epstein RJ, Parent A, Raphtis EM, Grostern R, Torczinski E. : Noninvasive diagnosis of epithelial downgrowth after penetrating keratoplasty using immunohistochemical analysis of resected corneal buttons. Cornea 25:727-733, 2006.
  39. Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G, Edelhauser HF: “Effect of Mitomycin C on the Corneal Endothelium When Used for Corneal Subepithelial Haze Prophylaxis Following Photorefractive Keratectomy.” J Refract Surg. 23:724-727, 2007
  40. Davis, MJ, Epstein, RJ, Dennis, RF, and Cohen JA: “Culture-positive endophthalmitis after implantation of intraocular Collamer lens”. J Cat Refr Surg 35: 1826-28, 2009
  41. Virasch, V, Majmudar PA, Epstein RJ, et al: “Reduced Application Time for Prophylactic Mitomycin-C in Photorefractive Keratectomy”. Ophthalmol. 117: 885-89, 2009
  42. Elderkin, SJ, and Epstein, RJ, Seldomridge DL:“Successful Treatment of Recurrent Epithelial Ingrowth Associated With Interface Fluid Syndrome, Flap Necrosis, and Epithelial Defects Following LASIK” J Refract Surg 27:70, 2011.
  43. Lane SS, Dubiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, Holland EJ, Lemp MA, McDonald JE, Silbert DI, Blackie CA, Stevens CA, and Bedi R : A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 31 :396-404, 2012
  44. Hou JH, Tannan A, Rubenstein JB, Lopez OI, McCoy K, Epstein RJ, Grostern RJ, Sugar J : Clostridium Perfringens endophthalmitis after penetrating keratoplasty with contaminated corneal allografts : A case series. Cornea 34:23-27, 2015
  45. Dalal,R.R.; Raber,I.; Dunn,S.P.; Weisenthal,R.; Sugar,J.; Hannush,S.; Epstein,R.; Feder,R.S.: Epithelial ingrowth following endothelial keratoplasty, Cornea 35: 465-470, 2016
  46. Rubinfeld RS, Epstein RH, Majmudar PA, Kim D, Choi M, and Epstein RJ : Transepithelial crosslinking retreatment of progressive corneal ectasia unresponsive to classic crosslinking. J Cat Ref Surg 43 : 131-135, 2017

Book Chapters

  1. Epstein RJ and Stulting RD: “Immunologically mediated corneal neovascularization in inbred mice”. In: Ocular Circulation and Neovascularization. BenEzra D, Ryan SJ, Glaser BM, and Murphy RP. Eds, Martinus Nijhoff/Dr W. Junk Publ., Dordrecht, Netherlands, 1987, pp. 341-348.
  2. Stulting RD, Abghari SZ, Epstein RJ, Nahmias AJ: “Host control of Herpes simplex virus Type-I (HSV) ocular disease in a genetically defined animal model. In: The Cornea. Trans. of the World Congress on the Cornea III. Cavanagh HD, ed. Raven Press, Ltd., New York, NY, 1988, pp. 405-411.
  3. Epstein RJ: Dendritic keratitis. “Will wiping it off wipe it out?” In: Ophthalmic Clinical Debates. Deutsch TA, ed. Year Book Medical Publishers, Inc., Chicago, IL, 1989, pp . 88-93.
  4. Basic and Clinical Science Course (BCSC), Section 8, “External Disease and Cornea” (with co-authors: Schwab I, Harris, DJ, Pflugfelder, SC, Wilhelmus KR, Perry P), AAO, 1992 edition
  5. Majmudar PA, Epstein RJ, “Antimetabolites in Ocular Surface Neoplasia” Schwab, I-ed. Current Opinion in Ophthalmology 9:IV: 35-39, 1998.
  6. Raviv T, Epstein RJ. “Astigmatism Management”. Int. Ophthalmol. Clin., (Refractive Surgery) 40:3: 183-198, 2000.
  7. Muller LT, Rao SN, Candal EM, Epstein, RJ. “Corneal Ectasia following LASIK Surgery”. In Probst, LE: LASIK: Advances, Controversies, and Custom, 2004 (Chapter 17). Charles Slack, Inc., Thorofare, NJ 08086.
  8. Letko E, Majmudar PA, Forstot SL, Epstein RJ, Rubinfeld RS: “UVA-light and Riboflavin-mediated Corneal collagen cross-linking”. In Trattler, W, Awdeh RM, Goldman DA: “Cornea/Refractive”, Spring 2011 (pp 63-76) Int. Ophthalmol. Clinics V. 51, #2, 2011. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia

Books Edited

  1. AAO Focal Points Monograph: Surgical Treatment of Pterygium- Gans LA, Vol. 14, #12, 1996. Reviewer and contributing editor.
  2. Gans L, Belin M, Epstein RJ, Wand M: “Surgical Treatment of Astigmatism”. AAO Focal Points Monograph 14: 12, 1996.

Other Publications

Letters To The Editor

  1. Epstein RJ, Luskin AT, Rana A: “The polyglandular syndrome”. Ann Int Med 92:711, 1980.
  2. Epstein RJ, Mets MB, Wong PWK, Mizen T: “Uveal colobomas and Klinefelter’s syndrome”. Am J Ophthalmol 98:241-243, 1984.
  3. Epstein RJ, Vastine DW, Fried WI: “Refining the technique for removing the Stableflex lens.” Ophthalmic Surg 20:599, 1989.
  4. Epstein RJ: “Viscoelastic agents”. Ophthalmic Surg 22:240, 1991.
  5. Epstein RJ: “Use of the disposable contact lens as a bandage contact lens”. Arch Ophthalmol 109: 1341, 1991.
  6. Epstein RJ: “Treatment of rheumatoid corneal ulcers”. Ophthalmology 99:842, 1992.
  7. Epstein RJ: “Transverse astigmatic keratotomy”. Refract Corneal Surg 8: 487, 1992.
  8. Epstein RJ: “General anesthesia and AISH”. J Cataract Refract Surg 19: 814, 1993.
  9. Epstein RJ, Robin JB: “Corneal graft rejection episode after excimer laser phototherapeutic keratectomy”. Arch Ophthalmol, 112:157, 1994.
  10. Epstein RJ: “Band keratopathy secondary to Herpes simplex or topical corticosteroid?” Arch Ophthalmol, 112: 578, 1994.
  11. Epstein RJ: “Refractive surgery goes mainstream: Establishing radial keratotomy services at a suburban community hospital”. J Refract Corneal Surg, 10: 378, 1994.
  12. Konowal A, Epstein RJ: “ALK vs. PK”. Ocular Surgery News, 14:4. 1996.
  13. Epstein RJ: “Is advancing wave-like epitheliopathy distinct from whorled microcystic dystrophy?” Ophthalmology, 105: 4, 1998.
  14. Epstein RJ, Brown SVL, Dennis R, Konowal-Allen A: “Accommodation of systemic acetazolamide and topical dorzolamide”. Ophthalmol. 105: 9, 1998.
  15. Epstein RJ: “Combining Keratoplasty and Cataract Surgery”. J Refract Corneal Surg, 25:603, 1999.
  16. Epstein RJ: “Cyclosporine and neovascularization”. Ophth. 106: 3, 1999.
  17. Raviv T, Majmudar PA, Dennis RF, Epstein RJ: “Mitomycin-C for post-PRK haze”. J Cat Ref Surg 26:1105, 2000.
  18. Majmudar PA, Raviv T, Dennis RF, Epstein RJ: “Subepithelial fibrosis after RK”. J Cat. Refract. Surg, 26: 113, 2000.
  19. Epstein RJ: “Extending the Standard Temporal Incision”. J Cat. Refract. Surg, 26: 1697-98, 2000.
  20. Epstein RJ: “Triple Anterior Stromal Ring Infiltrate Associated with Presumed HSV Keratitis”. Cornea 20(8):904-906, 2001.
  21. Rao S, Majmudar PA, Epstein RJ: “Transepithelial PTK/PRK Over Complicated LASIK Flaps”. J. Refract Surg: 17:47, 2001.
  22. Epstein RJ, Majmudar PA: “Pepper Spray in the Eye”. Ophthalmology 108: 1712, 2001.
  23. Epstein RJ: “Effect of topical trifluridine on Thygeson’s superficial punctate keratitis”. Ophthalmology 2002.
  24. Epstein RJ: “Control of Astigmatism in Cataract Surgery”. J Refr Surg 19. 9/03
  25. Epstein RJ, Brown SVL, Konowal A: “Endothelial changes associated with topical dorzolamide do appear to be significant”. Arch Ophthalmol 122;1089, 2004.
  26. Epstein RJ: “Words of praise”. Cat Refr Surg Today 4:15, June 2004
  27. Epstein, RJ and Majmudar, PA: “Alternative approach to the treatment of subepithelial fibrosis following radial keratotomy”.  Arch Ophthalmol 124:288, 2006.
  28. Klein, SR and Epstein RJ: “Ectasia after Photorefractive Keratectomy”. Ophthalmology 114:395-96, 2007.
  29. Epstein, RJ and Rao SN: “Early onset ectasia following LASIK: Long-term follow-up and correction”: J. Refract. Surg. 25: 250, 2009
  30. Larsen, B, Epstein RJ, Brown SVL: “Diagnosis of post-LASIK Chandler syndrome”. J Cat Refract Surg 35:3-4, 2009
  31. Davis, MJ, Packo KH, Epstein, RJ, Grostern RJ, and Cohen JA: Acanthamoeba endophthalmitis following penetrating keratoplasty for Acanthamoeba keratitis.  Arch Ophthalmol 128: 505, 2010
  32. Tailor UA and Epstein RJ: Corneal ectasia after laser in situ keratomileusis after laser thermal keratoplasty.  Cornea 29: 480, 2010
  33. Epstein, RJ and Epstein RH: Cataract and Refractive Surgery Today European Edition (CRST), 10/16- “Cover Focus: Meet the Epstein Family”, pp. 2-4.
  34. Epstein, RJ and Epstein RH: Cataract and Refractive Surgery Today US Edition (CRST), Feb., 2017- Cover Focus: “Family Tree”. ‘The Epsteins’- Vol. 17, pp. 41-46
  35. Brennan, K, Editor: Cover Focus- “Is Cross-linking at a Crossroads?”, Review of Ophthalmology, Spt. 2017, pp. 23-28.

Book Reviews

  1. Epstein RJ: Re: Brightbill F, “Corneal Surgery. Theory, Technique, and Tissue, 2nd Edition”. Am J Ophthalmol 547: 1994.
  2. Epstein RJ, Majmudar P: “Excimer Lasers in Ophthalmology. Principles and Practice.” Miller N, McGhee C, Taylor H, Gartry D, Trokel S., Boston, MA. Am J Ophthalmol, 1997.

Meeting Presentations with Published Abstracts (ARVO, ASCRS, CLAO, AAO, EBAA/Cornea Society, and OMIG)

  1. 5/80     ARVO, Orlando, FL.  Epstein RJ and Hughes WF:  “Corneal neovascularization induced by Con-A stimulated lymphocytes”.  Invest Ophthalmol Vis Sci 18:26 (Suppl..) 1980.
  2. 5/81     ARVO, Sarasota, FL.  Epstein RJ and Hughes WF:  “Histopathology of corneal neovascularization induced by Con-A stimulated lymphocytes”.  Invest Ophthalmol Vis Sci 20:171, (Suppl..) 1981.
  3. 5/83:    ARVO, Sarasota, FL.  Epstein RJ, Miller MT, Sugar J, Dennis RF, Karpik AG, Sugar A, Pinchoff BS, Gammon JA:  Mesenchymal dysgenesis associated with the fetal alcohol syndrome”.  Invest Ophthalmol Vis Sci 24:275, (Suppl..) 1983.
  4. 5/85     ARVO, Sarasota, FL.  Epstein RJ and Stulting RD: Lymphocyte-induced corneal neovascularization in inbred mice.  Invest Ophthal. Vis Sci 26:317, (Suppl.) 1985.
  5. 9/85:    AAO, San Francisco, CA.  Epstein RJ, Fernandes A, Stulting RD, Tigges M, Wright JD, and Gammon JA.  “The correction of aphakia in neonatal monkeys with extended-wear contact lenses”.   Ophthalmol 92:96, (Suppl..) 1985.
  6. 1/86:    CLAO, Las Vegas, NV. Epstein RJ, Fernandes A, Stulting RF, et al.  “The correction of aphakia in neonatal monkeys with extended-wear contact lenses: corneal studies”.  CLAO J 12:47, (Suppl..) 1986.
  7. 4/86:    ARVO, Sarasota, FL , Epstein RJ and Stulting RD:  “Genetic control of corneal neovascularization (CNV) is dominantly inherited and non-H-2”.  Invest Ophthalmol Vis Sci 27:46, (Suppl..) 1986.
  8. 4/86:    ARVO, Sarasota, FL.  Kindle JC, Epstein RJ, and Stulting RD:  “Cell-mediated immunity to Herpes simplex virus (HSV) in inbred mice”.  Invest Ophthal. Vis Sci 27:116, (Suppl..), 1986.
  9. 4/86:   ARVO, Sarasota, FL.  Halkias A, Epstein RJ, Stulting RD, Rodrigues M: Corneal opacities in DBA/2J mice”.  Invest Ophth. Vis Sci 27:203, (Suppl..) 1986.
  10. 11/86   AAO, New Orleans, LA.  Epstein RJ, Dreizen NG, Stulting RD, Seedor JA, Wilson LA, Cavanagh HD.  “Penetrating Keratoplasty (PK) for Herpes simplex keratitis (HSK) and keratoconus”.  Ophthalmol 93:96 (Suppl..) 1986.
  11. 11/86   AAO, New Orleans, LA.  Seedor JA, Stulting RD, Epstein RJ, Nay RE, Dreizen NG, Waring GO, Wilson LA, and Cavanagh HD.  “Survival of corneal grafts from donors supported by mechanical ventilation”.  Ophthalmol 93:114 (Suppl..) 1986.
  12. 11/86   AAO, New Orleans, LA.   Moore MB, McCulley JP, Bowman RW, Newton C, Cobo LM, O‘Day D, Johns K, Driebe WT, Epstein RJ, Wilson LA, Doughman DJ.  “Acanthamoeba keratitis A growing problem in soft and hard contact lens wearers”.  Ophthalmol 93:116 (Suppl..) 1986.
  13. 4/87     World Cornea Congress III,; Washington DC. Epstein RJ: Corneal vascularization: Causes and prevention. Cornea 6:51 (Suppl..) 1987.
  14. 4/87     World Cornea Congress III, : Washington DC. Stulting RD, Abghari SZ, Epstein RJ, Nahmias AJ: Host control of Herpes simplex (Type I) ocular infection in a genetically defined model. Cornea 6: 158 (Suppl..) 1987
  15. 5/87     ARVO, Sarasota, FL.  Epstein RJ, Stulting RD, and Hendricks RL: Corneal neovascularization in A/J mice induced by Interleukin-2.  Invest Ophthal Vis Sci 28:98, (Suppl..) 1987.
  16. 5/87     ARVO, Sarasota, FL.  Hendricks RL and Epstein RJ:  Bilateral ocular disease induced by unilateral corneal infection with HSV-1.  Invest Ophthalmol Vis Sci 28:368, (Suppl..) 1987.
  17. 11/87   Eye-Bank Association of America, Dallas, TX.  Seedor JA, Walsh GE, Wells JA, McCarty BE, Stulting RD, Epstein RJ and Smith P: “Corneas from ventilator supported donors:  Endothelial morphology and results of a survey”.  (Cornea Suppl. 1988)
  18. 11/87   AAO, Dallas, TX.  Epstein RJ, Fernandes A, and Gammon JA:  Extended-wear contact lenses for the correction of aphakia in infant children:  Corneal studies.  Ophthalmol 94:145, (Suppl..) 1987.
  19. 5/88     ARVO, Sarasota, FL.  Epstein RJ, Hendricks RL, Harris DM, Maloney JA:  “Dihematoporphyrin ether photodynamic therapy (DHE-PDT) for IL-2-induced 1 corneal neovascularization (CNV). Invest Ophthalmol Vis Sci 29:65 (Suppl..) 1988.
  20. 5/88     ARVO, Sarasota, FL.  Lekas NE , Epstein RJ, Harris DM, Hendricks RL:  Fluorescence microscopy of  vascularized corneas following injection of dihematoporphyrin ether (DHE).  Invest Ophthalmol Vis Sci 29:50 (Suppl..), 1988.
  21. 5/88     ARVO, Sarasota, FL.  Tumpey TM, Epstein RJ, Hendricks RL:  The effect of cellular immune tolerance on the immunopathology of HSV-1 keratitis.  Invest Ophthalmol Vis Sci 29:160 (Suppl..) 1988.
  22. 5/89     ARVO, Sarasota, FL.  Epstein RJ, Hendricks RL, Harris DM:  Photodynamic therapy (PDT) with the 514 nm argon laser for IL-2-induced corneal neovascularization (CNV). Invest Ophthalmol Vis Sci 30 (Suppl..):  364, 1989.
  23. 11/89   AAO, New Orleans, LA.   Epstein RJ: Problem patients in contact lens fitting: The monocular aphakic infant.  Ophthalmol 96 (Suppl..) 1989.
  24. 11/89   Castroviejo Society Meeting, New Orleans, LA.   Kay MD, Epstein RJ, Torczynski E:  Acute intraoperative suprachoroidal hemorrhage (AISH) associated with trans-scleral fixation of a posterior chamber IOL at the time of penetrating keratoplasty. (Cornea Suppl.1990)
  25. 10/90   American Academy of Ophthalmology (AAO) Annual Meeting, Atlanta, GA: Holland EJ, Alul EH, Epstein RJ, Meisler DM:  Anterior stromal infiltrates in Acanthamoeba keratitis. (Ophthalmol AAO Suppl.)
  26. 10/90   AAO, Atlanta, GA.  “Microsurgical keratoplasty: A practical course”- Lab Instructor, “Spherical correction of refractive errors”, “Clinical keratoplasty technique”- Lab Instructor. (Ophthalmol AAO Suppl.)
  27. 10/91   AAO, Anaheim, CA: “Microsurgical keratoplasty: A practical course”. Lab instructor. (Ophthalmol. AAO Suppl.)
  28. 10/91   Castroviejo Cornea Society; Anaheim, CA: “Photodynamic therapy for corneal neovascularization.”
  29. 11/92   AAO, Dallas, TX. Instructor- Microsurgical keratoplasty: A practical course. Lab course instructor.  (Ophthalmol AAO Suppl.)
  30. 5/91     ARVO, Sarasota, FL.  Robin SB, Rubenstein JB, Kay MD, Epstein RJ:  Haptic location of trans-sclerally fixated posterior chamber intraocular lenses in the cadaver eye.  Invest Ophthalmol Vis Sci 32:796 (Suppl..) 1991.
  31. 5/91     ARVO, Sarasota, FL.  Riley SF, Epstein RJ, Rubenstein JB, Dennis RJ:  Use of the Terry keratometer to aid suture adjustment with the single running technique.  Invest Ophthalmol Vis Sci 32:1236 (Suppl..), 1991.
  32. 5/91     ARVO, Sarasota, FL.  Gordon J, Johnson PJ, and the Fibronectin Study Group; Discontinuation of topical ophthalmic medications promotes healing of non-healing corneal epithelial defects. Invest Ophthalmol Vis Sci 32:1071 (Suppl..) 1991.
  33. 10/91   American Academy of Optometry, Eiden SB, Bass SJ, Epstein RJ: “Unilateral circumscribed posterior keratoconus” Optom Vis Sci 68:190 (Suppl..) 1991.
  34. 3/92     ARVO: Sarasota, FL. Robin SB, Epstein In the right eye, Rubenstein JB, Eiden SB, Waring GO: Corneal intraepithelial neoplasia: Bilateral disease and its association with contact lens wear.” Invest Ophthalmol Vis Sci 33:1292 (Suppl..), 1992.
  35. 11/92   AAO, Dallas, TX. Robin SB, Epstein RJ, Rubenstein JB, Eiden SB, Waring GO: Corneal intraepithelial neoplasia (CIN): Bilateral disease and its association with contact lens wear. Ophthalmology 99:122 (Suppl..) 1992.
  36. 11/93   AAO, Chicago, IL. Curnyn, KM, Rubenstein JB, Deutsch TA , Epstein RJ: Common office presentations of conjunctival lymphomas. Ophthalmol 1993;100 (Suppl..): 128.
  37. 11/93   Castroviejo Society; Chicago, IL. Capsulorhexis and the triple procedure. Cornea Suppl., 13: 98-99, 1994
  38. 3/94     ARVO; Sarasota, FL. Raphtis EM, Epstein RJ, Torczynski E, Rubenstein JB: Immunohistochemistry for the non-invasive diagnosis of epithelial downgrowth following penetrating keratoplasty. Invest Ophthalmol Vis Sci 35:1875 (Suppl..), 1994.
  39. 3/94     ARVO; Sarasota, FL. Hennessey MJ, Epstein RJ: Photodynamic therapy for corneal neovascularization (CNV): Clinical trials. Invest Ophthalmol Vis Sci 35: 1350 (Suppl..), 1994.
  40. 10/94   AAO, San Francisco, CA. Van Meter WS, Epstein RJ, Wood TO: Corneal astigmatism following removal of adjusted continuous keratoplasty suture, (Suppl..), Ophthalmol 101:123, 1994
  41. 10/95   AAO, Atlanta GA.  Epstein RJ, Konowal A, Dennis RF:  Application of computerized videokeratoscopy in guiding suture removal in post-penetrating keratoplasty patients. (Ophthalmol AAO Suppl.)
  42. 10/95   AAO meeting, Atlanta, GA: “Radial keratotomy on trial: Witness for the defense-speed of visual recovery and stability in RK”. (Ophthalmol AAO Suppl.)
  43. 5/96     Konowal A, Epstein RJ, Dennis RF, Brown SVL: “Irreversible corneal decompensation in patients treated with topical Dorzolamide.” Invest Ophthalmol & Vis Sci (ARVO Suppl.) 37:3, 1996.
  44. 10/96   AAO, Chicago, IL., Brown SVL, Epstein, RJ, Stock EL, Rubenstein J.  Scientific poster presentation:  Results of combined Ahmed valve and penetrating keratoplasty surgery. (Ophthalmol AAO Suppl.)
  45. 10/96   AAO, Chicago, IL. Lecturer with hands-on wet-lab:  Modern incisional refractive surgery.  (Ophthalmol AAO Suppl.)
  46. 10/96   AAO, Chicago, IL: Lecturer: Central Islands with the Summit Apex excimer laser. (Ophthalmol AAO Suppl.)
  47. 10/96   OMIG meeting (AJO Abstract), Epstein RJ, Nguygen, K: Thygeson’s superficial punctate keratitis in children and its response to trifluorothymidine”
  48. 10/96   AAO; Chicago, IL.   Mack RJS, Cutarelli P, Rubenstein JB, Mangan RB , Deutsch TA, Epstein RJ, Dune DS:  Central islands with the Summit Apex excimer laser, Ophthalmology (Suppl.) 1996; 103:129
  49. 3/97     ASCRS, Boston, MA: “PRK Complications: Management and Prevention”.
  50. 5/97     ARVO; Fort Lauderdale, FL.  Hahn S, Moore CR, Gaynes BL, Epstein RJ: Hyperopic Automated Lamellar Keratoplasty (H-ALK): Refractive and Visual Outcome in 41 Eyes. Invest Ophthalmol Vis Sci Suppl. (B772), 1979
  51. 3/98     Castroviejo Cornea Society; Majmudar PA, Brenart R, Epstein RJ: Topical Mitomycin-C for subepithelial fibrosis following RK. Cornea 17:2, 1998.
  52. 10/98   Konowal A, Epstein RJ, Dennis RF, Brown SVL: Poster: “Irreversible corneal decompensation in patients treated with topical Dorzolamide.” (AAO Ophthalmol. Suppl.)
  53. 11/98   Ocular Microbiology and Immunology Group OMIG); New Orleans, LA. Karp KO, Epstein RJ. Delayed keratitis following laser in-situ keratomileusis. Cornea Suppl. 18:3. 1999
  54. 11/98   Castroviejo Society Meeting, New Orleans, LA: Karp K, Epstein RJ.: “Pigmentary dispersion following laser in-situ keratomileusis (LASIK)”. Cornea 18: Suppl., 1999
  55. 10/99   AAO, Orlando FL. “Topical mitomycin-C treatment for corneal haze following refractive surgery”. (Ophthalmol. AAO Suppl.)
  56. 10/99   AAO, Orlando FL. “Breakfast with the experts” moderator- “LASIK Complications: Management and Avoidance”. (Ophthalmol. AAO Suppl.)
  57. 10/99   AAO, Orlando FL. Breakfast with the experts moderator-“LASIK techniques” (Ophthalmol. AAO Suppl.)
  58. 10/99   AAO, Orlando FL. “Astigmatism in the cataract patient”- Lab instructor (Ophthalmol. AAO Suppl.)
  59. 10/00   Raviv T, Rao S, Majmudar PA, Epstein RJ: “Visual outcomes of early flap slips after LASIK”, Ophthalmol (AAO supplement.), 10/2000
  60. 10/00   AAO; Dallas, TX. Co-presenter, skills transfer program, lab:  “Astigmatism in the Cataract Patient”. (Ophthalmol AAO Suppl.)
  61. 10/00   AAO; Dallas, TX. Discussant:  “The role of instrument sterilization and maintenance in DLK”. (Ophthalmol AAO Suppl.)
  62. 11/01   AAO, New Orleans LA. Lab instructor: “Astigmatism in the cataract patient”.  (Ophthalmol AAO Suppl.)
  63. 11/01   AAO, New Orleans, LA. Refractive Surgery Interest Group (RSIG) meeting: “Hansatome Pearls”.
  64. 5/02     ASCRS, Philadelphia, PA:
    “The use of Mitomycin-C in refractive corneal surgery”-(course)
    -“Mitomycin-C for corneal haze-PRO argument”
  65. 10/02   AAO: “The use of Mitomycin-C after laser refractive surgery”. Course instructor (AAO Ophth. Suppl.)
  66. 10/02   AAO, Orlando FL: “Astigmatism in the cataract patient”. Lab instructor. AAO Ophth. Suppl.)
  67. 10/02   AAO/Castroviejo Society Meeting, Orlando FL: “Mitomycin-C with PTK for Flap Complications”- Laura Muller, MD (Cornea suppl.)
  68. 4/03     ASCRS, San Francisco, CA.:
  69. “The expanding Role of Mitomycin-C in refractive corneal surgery”.
  70. “Design Review of Zyoptix System for LASIK Personalized Vision Correction”.
  71. 5/03     ARVO: Candal EM, Muller LT, Lane HA, Epstein RJ, Dennis RF, Majmudar PA:
  72. “Prophylactic Mitomycin-C for High-Risk PRK & LASEK. Invest Ophthal & Vis Sci 2003 (ARVO suppl.): 108.
  73. 11/03   AAO, Anaheim CA: ISRS/AAO pre-AAO meeting: “The role of antimetabolites in corneal refractive surgery”.
  74. 11/03   AAO, Anaheim CA: B&L Booth: “The Zyoptix system for personalized vision correction”
  75. 11/03   AAO, Anaheim CA: Poster #P0247: Klein, SR, Epstein RJ et. Al: “Poor visual outcomes following corneal refractive surgery in patients with clinically unsuspected pellucid marginal degeneration”.
  76. 11/03   AAO, Anaheim CA: Discussion of paper “Risk factors for corneal ectasia after LASIK” (by Randleman, et. al).
  77. 11/03   AAO, Anaheim CA: Lab instructor:”Astigmatism in the cataract patient” Course LAB250a.
  78. 11/03   AAO, Anaheim CA: Course co-instructor, “The use of mitomycin-C after laser refractive surgery”. Course #566
  79. 4/04     ASCRS, San Diego CA, -Candal, EM, Epstein RJ et.al.: “Role of wavefront analysis in screening keratoconus suspects before refractive corneal surgery”
  80. -Klein, SR, Epstein, RJ et al: “Comparison of time applications of mitomycin-C for haze prophylaxis in PRK”
  81. -Trattler, W, Amoils SP, Epstein RJ, Krueger RR, Hardten D, Smolek M: “Pearls for avoiding ectasia after LASIK” (course)
  82. -Majmudar PA, Carones F, Epstein RJ, Vigo L, Lee D, Zolotaryov A:
  83. “Expanding role of mitomycin-C in refractive surgery” (course)
  84. 10/04   AAO, New Orleans LA:Lab instructor:”Astigmatism in the cataract patient” Course LAB248b
  85. 11/04   AAO, New Orleans, LA: Course co-instructor, “The use of mitomycin-C after laser refractive surgery”. Course #183
  86. 10/04   AAO, New Orleans LA: Course Director, B&:L Hansatome certification course
  87. 10/04   AAO, New Orleans LA: JJ Bausch Ophthalmology Innovators Symposia Series: “Zyoptix Symposium, featuring Zyoptix Dual Workstation and Advanced Diagnostics: Would you do this case? Zyoptix in my practice.”
  88. 4/05     ASCRS, Washington, DC:
  89. -Trattler, W, Swanson MA, Hardten DR, Amoils P, Boxer Wachler B, Smolek,  M, Epstein RJ: ”Ectasia: Risk factors and treatment options“ (course)
  90. -Majmudar PA, Epstein RJ, Netto M, Carones F, Lee DH, Vigo L, Zolotaryov A: “Update on the role of Mitomycin-C in Refractive Surgery” (course).
  91. 10/05   AAO, Chicago, IL: Course Co-instructor, “Astigmatism in the cataract patient”, Course #LAB244a
  92. 10/05   AAO, Chicago, IL: Course Co-instructor, “The use of mitomycin C after laser refractive surgery”, Course #462
  93. 3/06     ASCRS, San Francisco CA:
    1. Course instructor: “Surface ablation for complicated Post-refractive Surgery and Postsurgical eyes (Course #18-403).
    2. Panelist: “Cataract Section: Cataract challenges, AMD lenses, LAL, CTR”
  94. 11/06   ISRS/AAO, Las Vegas, NV: Invited presentation: “Treating buttonhole LASIK flaps”.
  95. 11/06   AAO, Las Vegas, NV: Course Co-instructor, “Astigmatism in the cataract patient”, Course #LAB349b
  96. 11/06   AAO, Las Vegas NV: Course Co-instructor, “The use of mitomycin C after laser refractive surgery”, Course #574
  97. 11/07   AAO, New Orleans , LA: Course Co-instructor, “Astigmatism in the cataract patient”, Course #116
  98. 11/07   AAO, New Orleans , LA: Co-Author, “Reduced application time for prophylactic Mitomycin-C in High-Risk Surface Ablation” (with Virasch VV, Majmudar PA, Dennis Rf, and Vaidya NS)
  99. 11/08   AAO, Atlanta GA: Course Co-instructor, “Astigmatism in the cataract patient”, Course #230a
  100. 10/09   AAO, San Francisco CA: Course Co-instructor, “Astigmatism in the cataract patient”
  101. 10/10   AAO, Chicago. Course Co-instructor, “Astigmatism in the cataract patient”
  102. 3/11     ASCRS, San Diego: Course co-instructor, #29-104: “Advances in corneal                                      collagen crosslinking for keratoconus, post-LASIK ectasia, and corneal infections
  103. 10/11   AAO, Orlando FL: Course Co-instructor, “Astigmatism in the cataract patient”
  104. 10/11   AAO, Orlando FL: Poster #363 Co-author: Rubinfeld RS, Trattler WB, Majmudar PA, Epstein RJ, Adi M, Wallace D, McCall TL, Martin NF, Letko E, Intili A, Perez G: “Multicenter evaluation of epithelial-on vs epithelial-off corneal collagen crosslinkng for keratoconus and pos-LASIK ectasia”.
  105. 10/11   AAO, Orlando FL: Cornea Day pre-AAO invited presentation: “Corneal topography and tomography interpretation for the cataract surgeon: Implications for premium IOL’s”
  106. 10/11   AAO, Orlando FL: Cornea Society presentation co-author: Rubinfeld R, Trattler W, Epstein R, Forstot L, Talamo J, Khell J, Perez G: “Multicenter comparative evaluation of epithelium-on cross-linking vs epithelium-off corneal collagen cross-linking (CXL)
  107. 4/12   ASCRS Chicago: “Anterior segment complications after glaucoma surgery (Cornea Society symposium)
  108. 5/10/12 ARVO, Ft. Lauderdale FL: Rubinfeld R, Trattler W, Perez, G, Kaiser C, Koreishi A, Majmudar P, Epstein RJ, Bafna S, Malahotra R- “Outcomes following epithelium-on crosslinking in patients who received the treatment on one or both eyes”- 6786/D950
  109. 11/12   AAO, Chicago IL: Co-instructor, “Astigmatism in the cataract patient”
  110. 4/13   ASCRS, San Francisco CA: Course instructor “Mastering transepithelial and epi-off corneal CXL for keratoconus and post-LASIK ectasia (course #1536796)
  111.   5/13   ARVO, Seattle WA: Tannan, A, Epstein, Jonathan Rubenstein; Vanee Virasch; Charles Faron, O.D: “Utility of intraoperative wavefront aberrometry in post-refractive cataract patients” (pres. #3004, poster #C0095).
  112.   5/13   ARVO, Seattle WA: Raciti, M, Epstein, RJ, et al:” Corneal Endothelial Cell Density Following Transepithelial Collagen Cross-Linking” (Abstract # 1564125)
  113. 10/13   ESCRS, Amsterdam: Roy Rubinfeld, MD, William Trattler, MD, Rosane Correa, MD, Gabriela Perez BS, Randy Epstein, MD, Gregg Berdy, MD, Ranjan Malahotra, MD: “Evaluation of Epi-On Corneal Collagen Cross-Linking (CXL) at 6 months and 1 year Follow Up in Patients Diagnosed with Keratoconus”
  114. 4/14     ASCRS, Boston MA: Course # 28-106: “Early Detection and Management of Keratoconus Including Collagen Crosslinking”
  115. 10/14   AAO, Chicago IL:
  116. Keynote Lecture, ISRS pre-AAO “Refractive Surgery 2014”:
    1. “Mitomycin-C: Uses and Abuses in Corneal Refractive Surgery”
    2. Great Debate: Corneal Crosslinking: “Epithelium-on” (SYM11)
    3. Course LAB143a: “Toric alignment imaging and astigmatism surgery”
    4. Course LAB107a: “Crosslinking”
  117. 11/15   AAO, Las Vegas NV: Lab instructor: “LAB 125a- Toric alignment imaging and astigmatism surgery” and “LAB 104a- Crosslinking”
  118. 10/16   AAO, Chicago IL: Lab instructor: “LAB 134a- Toric alignment imaging and astigmatism surgery”
  119. 11/17   AAO, New Orleans LA: Lab instructor: “LAB 145a: Toric alignment imaging and astigmatism surgery”
  120. 4/18     ASCRS, Washington, DC- Lab co-instructor, Surgical Management of Astigmatism Skills Lab, Course STS-2
  121. 5/18     ARVO, Honolulu HI: Poster #2875470 co-author: “Demystifying DMEK: A comparison of donor preparation”: Epstein R, Majmudar, PA, Epstein RJ, Rubenstein, JB
  122. 10/18   AAO, Chicago IL: Lab instructor “Lab 142a-  Toric Alignment Imaging and Astigmatism Surger
  123. 5/18     Poster presentation, “PDEK: Is it any better than DMEK?” American Society of Cataract and Refractive Surgery, San Diego, CA, May 2019.
  124. 5/18     ASCRS, San Diego CA: Lab co-instructor, Surgical Management of Astigmatism Skills Lab, Course STS-2
  125. 10/19   AAO, San Francisco CA: Lab instructor “Lab 142a-  Toric Alignment Imaging and Astigmatism Surgery

Audio-Visual Educational Materials

  1. Epstein RJ.  “Refractive Practice Pearls”.  Audio-Digest Ophthalmology 41:12. 2/03.
  2. Epstein RJ. “LASIK Complications, Antimetabolites and Refractive Surgery.” “The Management of Astigmatism with Cataract Surgery”.   Audio-Digest Ophth. 5/03.
  3. Epstein RJ.  “Expanding Applications for NSAIDs:  The Inflammatory Response in the Eye”.  Audioconference series, 7/03-10/03.

Patients and Inventions

The “Epstein-Lindstrom aspirating LASIK lid speculum”, #E-4118, (Storz/B&L Surgical patent)

Online Publications

  1. 2/10/2020: MSN.com  Joan Raymond US Yesterday • 2:33 PM
  2. 5 eye problems you shouldn’t ignore, from floaters to pains

See the Best withChicago CorneaConsultants

Request an Appointment
Contact us media
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (800) 8-CORNEA.
Contact Us